Priola AM, Gned D, Parvis G, et al. Usefulness of diffusion-weighted magnetic resonance imaging for assessing early treatment response in lymphoma patients. Acta Radiol (in press). DOI: 10.1177/0284185114554254.
2.
Hagtvedt T, Seierstad T, Lund KV, et al. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma. Acta Radiol 2014 Feb 28 [Epub ahead of print].
3.
HorgerMClaussenCKramerU. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity – A preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging. Eur J Radiol2014; 83: 1655–1664.
4.
WuWENerishoSDastidarP. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma – a whole-body MRI and diffusion-weighted imaging study. NMR Biomed2013; 26: 1186–1194.
5.
RevheimMEHoleKHBrulandØS. Multimodal functional imaging for early assessment in GIST patients treated with imatinib. Acta Oncol2014; 53: 143–148.
